Preferred Label : Bleeding disorder, platelet-type, 13, susceptibility to;
Symbol : BDPLT13;
CISMeF acronym : BDPLT13;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Bleeding disorder, susceptibility to, due to defective platelet thromboxane a2 receptor;
Description : Susceptibility to platelet-type bleeding disorder-13 is due to a defective thromboxane
A2 receptor on platelets. The susceptibility is inherited in an autosomal dominant
pattern, but clinical features, including mild mucocutaneous bleeding, occur only
in the presence of a 'second hit' affecting platelet function; this second hit may
be either in the TBXA2R gene or in another gene affecting the coagulation cascade
(summary by Mumford et al., 2010).;
Inheritance : Autosomal dominant;
Molecular basis : Susceptibility conferred by mutation in the platelet thromboxane A2 receptor gene
(TBXA2R, 188070.0001);
Prefixed ID : #614009;
Origin ID : 614009;
UMLS CUI : C3279614;
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)